510(k) device
Elecsys proBNP II, Elecsys proBNP II STAT
Roche Diagnostics · Test, Natriuretic Peptide (NBC, Class II) · First FDA decision Feb 5, 2008, newest Jul 21, 2023Heart attack and heart failure blood testsHeart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
0
Naming "Elecsys proBNP II"
MAUDE reports
50
Brand "Elecsys proBNP II", since 2015
PubMed studies
7
Mentioning "Elecsys proBNP II"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Elecsys proBNP II, Elecsys proBNP II STAT
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
K223637 · Decided Jul 21, 2023 · 228 days after receipt
Device type: Test, Natriuretic Peptide (NBC) · Laboratory Medicine & Pathology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- B-type Natriuretic Peptide (BNP) TestingLocal determinationIn effectL33573Wellpoint FederalUpdated Jul 14, 2026
- B-type Natriuretic Peptide (BNP) TestingLocal determinationIn effectL35526Noridian Healthcare Solutions, LLCUpdated Feb 23, 2026
- B-type Natriuretic Peptide (BNP) TestingLocal determinationIn effectL34410Palmetto GBAUpdated Dec 22, 2025
- B-type Natriuretic Peptide (BNP) TestingLocal determinationIn effectL33943CGS Administrators, LLCUpdated Nov 26, 2025
- B-type Natriuretic Peptide (BNP) TestingProposed local determinationProposedDL34410Palmetto GBAUpdated Jan 31, 2025
- B-Type Natriuretic Peptide (BNP)Local determinationIn effectL33267First Coast Service Options, Inc.Updated Nov 21, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "Elecsys proBNP II", any status and sponsor, newest update first.
No registered device study names "Elecsys proBNP II".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Elecsys proBNP II", and for the whole product code for context.
This brand
50 reports: 50 malfunction, 0 injury, 0 death
Whole product code NBC
183 reports: 178 malfunction, 5 injury, 0 death
Newest reports for this brand
- Elecsys proBNP IIMalfunction
1823260-2026-04180 · Received Oct 9, 2026 · Event dated Jan 17, 2026
Device type: Test, Natriuretic Peptide (NBC)
Device problem as coded: Low Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Elecsys proBNP II"[tiab]. The summary above synthesizes these.
- Microfluidic Digital Immunoassay for Point-of-Care Detection of NT-proBNP from Whole Blood.
Chen C, Porter R, Zhou X, et al. · Anal Chem · 2024Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't
- Evaluation of a New NT-proBNP Immunoassay on an Automated Core Laboratory System.
Logan S, Di Meo A, Shapero S, et al. · J Appl Lab Med · 2024Evaluation Study
- Evaluation of Analytical Performances and Comparison of 3 NT-proBNP Assays for Diagnosing Heart Failure.
Cho J, Lee JH, Lee SG · Arch Pathol Lab Med · 2023
- Smartphone-Enabled Point-of-Care Testing for Prehospital Stroke Diagnosis.
Menéndez-Valladares P, M Delgado R, Núñez-Jurado D, et al. · Prehosp Emerg Care · 2026
- Evaluation of a New Antibody-Based NT-proBNP Assay for Acute Dyspnea in the Emergency Department.
Allen BR, Guidi JL, Headden G, et al. · Clin Chem · 2026
- [Level of N-terminal fragment of brain natriuretic peptide progenitor and atherosclerotic damage of brachocephalic arteries in patients with rheumatoid arthritis with inefficiency and/or injurability of basic anti - inflammatory treatment].
Gerasimova EV, Popkova TV, Martynova AV, et al. · Ter Arkh · 2019
- Diagnostic utility of total NT-proBNP testing by immunoassay based on antibodies targeting glycosylation-free regions of NT-proBNP.
Li L, Semenov AG, Feygina EE, et al. · Clin Chem Lab Med · 2023
Other devices of this type
Also filed under product code NBC.
- Triage Bnp Test for Beckman Coulter Immunoassay Systems, Model 98200Biosite Incorporated · 510(k) 2006
- Elecsys Probnp ImmunoassayRoche Diagnostics Corp. · 510(k) 2005
- Triage B-Type Natriuretic Peptide (Bnp) TestBiosite Incorporated · De Novo 2002
- Access BNP IIBeckman Coulter, Inc. · 510(k) 2026
- Access NT-proBNPBeckman Coulter, Inc. · 510(k) 2026
- Alere NT-proBNP for Alinity iAxis-Shield Diagnostics, Ltd. · 510(k) 2026
- VITROS Immunodiagnostic Products NT-proBNP II Reagent PackOrtho Clinical Diagnostics · 510(k) 2021
- Stratus Cs Acute Care Nt-Probnp Testpak, Model CpbnpmDade Behring, Inc. · 510(k) 2007
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.